The results of these studies were substantially consistent and showed a marked reduction in serum PTH, with moderate (although still highly significant) reductions in serum calcium, phosphate and Ca × P.
← all excerpts
Clinical outcomes in secondary hyperparathyroidism and the potential role of calcimimetics.
1
—
—